AI to help fight asbestos-related cancer

Image source: Shutterstock/create jobs 51

News • Malignant Pleural Mesothelioma

AI to help fight asbestos-related cancer

International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes.

Mesothelioma is caused by breathing asbestos particles and most commonly occurs in the linings of the lungs or abdomen. Currently, only seven per cent of people survive five years after diagnosis, with a prognosis averaging 12 to 18 months. New research undertaken by the Leicester Mesothelioma Research Programme has now revealed, using AI analysis of DNA-sequenced mesotheliomas, that they evolve along similar or repeated paths between individuals. These paths predict the aggressiveness and possible therapy of this otherwise incurable cancer. The researchers published their findings in the journal Nature Communications.

Mesotheliomas follow ordered paths of mutations during development, and [...] these so-called trajectories predict not only how long a patient may survive, but also how to better treat the cancer

Dean Fennell

Professor Dean Fennell, Chair of Thoracic Medical Oncology at the University of Leicester and Director of the Leicester Mesothelioma Research Programme, said: “It has long been appreciated that asbestos causes mesothelioma, however how this occurs remains a mystery. Using AI to interrogate genomic ‘big data’, this initial work shows us that mesotheliomas follow ordered paths of mutations during development, and that these so-called trajectories predict not only how long a patient may survive, but also how to better treat the cancer – something Leicester aims to lead on internationally through clinical trial initiatives.”

While use of asbestos is now outlawed – and stringent regulations in place on its removal – each year around 25 people are diagnosed with mesothelioma in Leicestershire and 190 are diagnosed in the East Midlands. Cases of mesothelioma in the UK have increased by 61% since the early 1990s. Until very recently, chemotherapy was the only licenced choice for patients with mesothelioma. However, treatment options start to become limited once people stop responding to their treatment.


Source: University of Leicester

29.03.2021

Read all latest stories

Related articles

Photo

News • Strand-seq

AI analysis of cancer mutations: a promising step towards new therapies

Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This could pave the way for personalized cancer treatments.

Photo

Article • AI-based personalized medical care

I³lung: EU launches lung cancer initiative

This summer, The European Commission launched I3lung, a new research initiative as a part of Horizon Europe, the EU’s research and innovation program. This research initiative aims to create a…

Photo

News • AI vs. NSCLC

Streamlining lung cancer radiotherapy with Deep Learning

UK researchers developed and validated a deep learning algorithm that can identify and outline a non-small cell lung cancer (NSCLC) tumor on a CT scan within seconds.

Related products

contextflow Advance Chest CT *

Artificial Intelligence

Dedalus · contextflow Advance Chest CT *

Dedalus HealthCare GmbH
3DQuorum SmartSlices

Artificial Intelligence

Hologic · 3DQuorum SmartSlices

Hologic, Inc.
Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon · Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
AI-Rad Companion

Artificial Intelligence

Siemens Healthineers · AI-Rad Companion

Siemens Healthcare GmbH
Aquilion Exceed LB

Oncology CT

Canon · Aquilion Exceed LB

Canon Medical Systems Europe B.V.
Subscribe to Newsletter